NCT07894458

MRD-Guided Postoperative Surveillance and Adaptive Treatment for Resectable Lung Cancer

RecruitingNAINTERVENTIONAL

Trial Details

Start: 2026-08-12Est. Completion: 2027-10-31

Enrollment target: 100 participants

Locations

Contact

Intrahepatic Cholangiocarcinoma (Icc)

This is a phase III, multicenter, open-label, randomized controlled trial designed to evaluate the efficacy and safety o…

Guangzhou, ChinaEst. completion Jan 2030

Non-small Cell Lung Cancer Stage IV

The goal of this clinical trial is to confirm that SB27 works in the same way as Keytruda in metastatic non-squamous non…

Banja Luka, Bosnia and HerzegovinaEst. completion Mar 10, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.